After this period, your provider may recommend: A 1-2 month break before resuming Continued treatment with periodic monitoring Dose adjustments based on your response Long-term use beyond 6 months should include periodic lab testing (IGF-1 levels, metabolic panel) and provider evaluation
Cytoscape (Shannon et al., 2003): A powerful software package, which can be used to visualize and analyzed biological networks, including pathways, PPIs, and protein-protein similarity networks
Loren Pickart, the peptides discoverer, estimated toxic action beginning around 22,500mg, a dose that would be essentially impossible to reach accidentally
This study investigated the relationship between pre-stroke frailty and various stroke outcome parameters
Long-term and short-term animal studies have reported no consistent evidence of organ toxicity or reproductive disruption under controlled laboratory conditions